Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR et al. Inflammation, immunity, and hypertension. Hypertension 2011; 57 (2): 132–140.
2. Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C . Essential hypertension: is there a role for inflammatory mechanisms? Cardiol Rev 2009; 17 (5): 216–221.
3. Hage FG, McCrory MA, Szalai AJ . C-reactive protein and cardiovascular disease: Lessons learned from studying genetically engineered mice. In: Nagasawa S ed C-Reactive Protein – N Res. Nova Publishers: Hauppauge NY, 2008 ISBN: 978-1-60692-237-8..
4. Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375 (9709): 132–140.
5. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359 (21): 2195–2207.
Cited by
145 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献